News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search Vall d'Hebron shows long-term safety of CAR-T therapy in aggressive lymphoma patients 26/03/2025 Vall d'Hebron leads a guide for the prevention of cardiovascular diseases in women 20/03/2025 An innovative model to predict left ventricular thrombus after a heart attack 24/01/2025 Pollution reduces the benefits of rehabilitation after a heart attack by 90% 02/01/2025 Vall d'Hebron develops a predictive model to calculate cardiovascular risk in women 05/12/2024 The use of ECMO at Vall d'Hebron improves the survival of patients with cardiac arrest 17/10/2024 La Marató finances three Vall d'Hebron projects in cardiovascular health 08/11/2023 Vall d'Hebron discovers a new antibody for the diagnosis of patients with scleroderma 24/10/2023 Vall d'Hebron trains future professionals in the use of gene therapy 30/06/2023 62% of children with a ventricular assist device receive a new heart 03/05/2023 Vall d’Hebron inclou el primer pacient en un estudi pioner en teràpia CAR-T per al lupus 23/03/2023 A review highlights the influence of pollution on cardiovascular health 16/01/2023 Vall d’Hebron and General Electric co-develop the first 4D transoesophageal probe 30/11/2022 Arterial pulse measurement could help detect asymptomatic arrhythmias 11/05/2022 A project led by Laia Ventura wins an award from the General Council of Nursing 09/02/2022 Vall d’Hebron and IDIAP Jordi Gol join forces to research cardiovascular diseases and diabetes 30/11/2021 Vall d'Hebron named by CatSalut as a Clinical Expertise Unit (UEC) in the fields of rare immune diseases within the area of systemic autoimmune diseases. 17/08/2021 Vall d'Hebron releases four innovative works on different systemic diseases 04/08/2021 Dr. Joan Comella is appointed treasurer of ICORD and Dr. Mireia del Toro joins the board 10/05/2021 Vall d’Hebron includes the world’s first patient in Pfizer’s Phase 3 gene therapy clinical trial for Duchenne muscular dystrophy 08/01/2021 Pagination 1 2 Next › Next page Last » Last page